Althea Acquires Altus’ Technologies

Xconomy San Diego — 

San Diego CRO Althea Technologies says it is acquiring the assets and IP portfolio of Altus Pharmaceuticals, a Waltham, MA, biotech that filed for bankruptcy liquidation seven months ago. Financial terms were not disclosed. Altus had been developing an injectable human growth hormone to treat diseases.  Althea said applications of Altus’ technology range from therapeutics to protein purification and catalysis.